Global Artificial Intelligence in Genomics Market Drives Scientific Breakthroughs, Surpassing USD 13096 Million with Impressive Market Growth and Expanded Adoption
Advancements in AI-powered Genomic Analysis Propel the Global Market to New Heights
The global artificial intelligence (AI) in genomics market has achieved remarkable success, exceeding USD 13096 Million, driven by groundbreaking applications of AI in genomic research and personalized medicine. The market showcases robust growth, substantial market share expansion, and increasing adoption across the life sciences industry.
The global artificial intelligence in genomics market, valued at USD 464.50 million in 2022, has experienced extraordinary growth and is projected to maintain an impressive compound annual growth rate (CAGR) of 51.8% during the forecast period from 2023 to 2030.
Key players in the global artificial intelligence in genomics market include IBM, Cambridge Cancer Genomics, NVIDIA Corporation, Verge Genomics, Molecular Match Inc., Deep Genomics, Microsoft, Free nome Holdings, Inc., Benevolent AI, Fabric Genomics Inc. and Other Players.
These companies are at the forefront of developing cutting-edge AI algorithms, genomics software platforms, and genomic analysis tools, shaping the future of personalized medicine and precision genomics.
Get Report Sample @ https://www.snsinsider.com/sample-request/1903
AI’s integration into genomics has revolutionized genetic analysis and genomic sequencing, accelerating scientific discoveries and unlocking the potential of personalized medicine. AI-powered algorithms and machine learning techniques enable researchers to analyze vast genomic datasets, identify disease-causing genetic variations, and predict individual disease risks with unprecedented accuracy.
Market growth is further propelled by the rising adoption of AI in drug discovery and development. AI-driven genomics assist pharmaceutical companies in identifying potential drug targets, optimizing clinical trial designs, and predicting patient responses to treatments, resulting in more efficient drug development pipelines and improved patient outcomes.
The global artificial intelligence in genomics market encompasses a wide array of applications, including genomic data analysis, variant interpretation, gene expression profiling, and genetic diagnostics. Additionally, advancements in AI-driven genomic editing technologies, such as CRISPR-Cas9, hold immense promise for gene therapy and precision medicine.
Artificial Intelligence In Genomics Market Segmentation as Follows:
By Offering Type
· Software
· Services
By Technology
· Machine Learning
· Deep Learning
· Supervised Learning
· Reinforcement Learning
· Unsupervised Learning
By Functionality
· Genome Sequencing
· Gene Editing
· Clinical Workflows
· Predictive Genetic Testing & Preventive Medicine
By end user
· Pharmaceutical & Biotech Companies
· Healthcare Providers
· Research Centers, Academic Institutes, &
· Government Organizations
Geographically, North America dominates the global artificial intelligence in genomics market, attributed to its advanced biotechnology and pharmaceutical industries, robust research infrastructure, and government support for genomics research. However, the market in Europe, Asia-Pacific, and other regions is also witnessing significant growth, driven by increasing investments in genomics research and a growing number of collaborative initiatives.
As the global artificial intelligence in genomics market continues to advance, it holds immense potential to revolutionize genetic research, accelerate drug discovery, and pave the way for personalized medical treatments. The market’s growth trajectory is expected to be fueled by continuous technological innovations, cross-industry collaborations, and a focus on leveraging AI’s capabilities to decode the complexities of the genome.
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand — Head of Business Development & Strategy
info@snsinsider.com
Phone: +1–415–230–0044 (US) | +91–7798602273 (IND)
Website: https://www.snsinsider.com/
